Literature DB >> 849560

Carcinoembryonic antigen: 3 years' experience in a cancer clinic.

M Koch, T A McPherson, D W Morrish.   

Abstract

Long-term studies on multiple plasma samples of 988 patients with carcinoma of entodermal origin indicate that, especially for patients with colorectal cancer, repeatedly elevated or rising carcinoembryonic antigen (CEA) values are a sign of poor prognosis when found preoperatively, postoperatively or during chemotherapy. Persistently elevated CEA values in postoperative patients apparently free of disease are a useful marker for early detection of recurrence or metastases. Normal CEA values are of little or no prognostic value.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849560      PMCID: PMC1879415     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  4 in total

1.  Carcinoembryonic antigen: clinical correlation with chemotherapy for metastatic gastrointestinal cancer.

Authors:  A T Skarin; R Delwiche; N Zamcheck; J J Lokich; E Frei
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

2.  Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.).

Authors:  J P Mach; P Jaeger; M M Bertholet; C H Ruegsegger; R M Loosli; J Pettavel
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

Review 3.  The present status of DEA in diagnosis, prognosis, and evaluation of therapy.

Authors:  N Zamcheck
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

4.  Usefulness of serial serum carcinoembryonic antigen (CEA) determinations during anticancer therapy or long-term follow-up of gastrointestinal carcinoma.

Authors:  M Ravry; C G Moertel; A J Schutt; V L Go
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

  4 in total
  1 in total

Review 1.  Blood CEA levels for detecting recurrent colorectal cancer.

Authors:  Brian D Nicholson; Bethany Shinkins; Indika Pathiraja; Nia W Roberts; Tim J James; Susan Mallett; Rafael Perera; John N Primrose; David Mant
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.